NONTP - Overview: Neuro-Oncology Panel, Tumor

Test Catalog

Test Name

Test ID: NONTP    
Neuro-Oncology Panel, Tumor

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying mutations that may support a diagnosis for patients with tumors of the central nervous system

 

Identifying mutations that may help determine prognosis for patients with tumors of the central nervous system

 

Identifying central nervous system tumors that may respond to targeted therapies by assessing multiple gene targets simultaneously

 

Identifying specific mutations within genes known to be associated with response or resistance to specific cancer therapies

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

Highlights

This next-generation sequencing assay interrogates targeted regions across 50 genes, including TERT, ATRX, IDH1/2, EGFR, BRAF, CIC, FUBP1, and H3F3A to assess for the presence of somatic mutations.

 

This assay is for diagnosis, prognostication, and therapeutic management for tumors of the central nervous system.

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
SLIRVSlide Review in MGNo, (Bill Only)Yes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, slide review will always be performed at an additional charge.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR)-Based Next-Generation Sequencing

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Neuro-Oncology Panel, Tumor

Aliases Lists additional common names for a test, as an aid in searching

ATRX
BRAF
IDH1
IDH2
TERT
EGFR
CIC
FUBP1
H3F3A
Brain tumor
Central nervous system (CNS) cancers
Oncology panel
Next Gen Sequencing Test
NGS